Clinical Trial Update: Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing myocardial perfusion, oxidative metabolism, and fibrosis in heart failure with preserved ejection fraction (HFpEF) has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure
• Heart Failure Diastolic
• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Marvin W. Kronenberg, M.D. | Conditions: Heart Failure, Diastolic, Diastolic Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2021-02-02